Superficial bladder cancer is not a rare disease. Intravesical therapy of superficial bladder tumors using Bacillus Calmette-Guerin (BCG) has been established worldwide since the end of the seventies, and since that time has found an ever-widening acceptance. In spite of this, many questions regarding its application and therapeutic success have remained unanswered. The partly conflicting results of studies require interpretation and explanation. This educational website closes this gap, which has existed for some considerable time, and for the first time provides a complete electronic overview of the available knowledge on superficial bladder cancer and intravesical BCG therapy. It gives helpful opinions on applications and provides information on side effects as well as a complete list of all complications described in the world literature. The therapeutic success of intravesical BCG therapy is demonstrated in a comparison with otherwise untreated patients (TUR) and also in comparison with intravesical chemotherapy. Furthermore, we have included a brief, comprehensible explanation of the functional mechanism.

This educational program represents an urgently needed, clear compilation of information on intravesical BCG therapy. In my opinion, every practising urologist should frequently update his knowledge on this website.

A. Böhle